Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages

Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transform...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 11; no. 11; p. e0166433
Main Authors Soldano, Stefano, Pizzorni, Carmen, Paolino, Sabrina, Trombetta, Amelia Chiara, Montagna, Paola, Brizzolara, Renata, Ruaro, Barbara, Sulli, Alberto, Cutolo, Maurizio
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 15.11.2016
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0166433

Cover

Abstract Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types. ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.
AbstractList Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Methods Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. Results ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types. Conclusion ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.
Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells.BACKGROUNDAlternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells.Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography.METHODSCultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography.ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types.RESULTSET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types.ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.CONCLUSIONET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.
Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells.Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography.ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types.ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.
Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ET.sub.A and ET.sub.B). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ET.sub.A/B RA, bosentan 10.sup.-5 M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ET.sub.A/B RA treatment in both cultured cell types. ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ET.sub.A/B RA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.
Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ET.sub.A and ET.sub.B). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Methods Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ET.sub.A/B RA, bosentan 10.sup.-5 M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. Results ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ET.sub.A/B RA treatment in both cultured cell types. Conclusion ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ET.sub.A/B RA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.
Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ET A and ET B ). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Methods Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ET A/B RA, bosentan 10 -5 M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. Results ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ET A/B RA treatment in both cultured cell types. Conclusion ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ET A/B RA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.
Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing pro-fibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its pro-fibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ETA/BRA, bosentan 10-5M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types. ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.
Audience Academic
Author Sulli, Alberto
Soldano, Stefano
Ruaro, Barbara
Trombetta, Amelia Chiara
Montagna, Paola
Pizzorni, Carmen
Cutolo, Maurizio
Paolino, Sabrina
Brizzolara, Renata
AuthorAffiliation Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy
Universitatsklinikum Freiburg, GERMANY
AuthorAffiliation_xml – name: Universitatsklinikum Freiburg, GERMANY
– name: Research Laboratory and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, Genoa, Italy
Author_xml – sequence: 1
  givenname: Stefano
  surname: Soldano
  fullname: Soldano, Stefano
– sequence: 2
  givenname: Carmen
  surname: Pizzorni
  fullname: Pizzorni, Carmen
– sequence: 3
  givenname: Sabrina
  surname: Paolino
  fullname: Paolino, Sabrina
– sequence: 4
  givenname: Amelia Chiara
  surname: Trombetta
  fullname: Trombetta, Amelia Chiara
– sequence: 5
  givenname: Paola
  surname: Montagna
  fullname: Montagna, Paola
– sequence: 6
  givenname: Renata
  surname: Brizzolara
  fullname: Brizzolara, Renata
– sequence: 7
  givenname: Barbara
  surname: Ruaro
  fullname: Ruaro, Barbara
– sequence: 8
  givenname: Alberto
  surname: Sulli
  fullname: Sulli, Alberto
– sequence: 9
  givenname: Maurizio
  surname: Cutolo
  fullname: Cutolo, Maurizio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27846260$$D View this record in MEDLINE/PubMed
BookMark eNqNkl2LEzEUhgdZcT_0H4gOeLNetOZrkowXQimrW9hFL_Q65GvalDSpM5mF_nsz26m0yyKSi4ST57w5eXkvi7MQgy2KtxBMIWbw0zr2bZB-us3lKYCUEoxfFBewxmhCEcBnR-fz4rLr1gBUmFP6qjhHjBOKKLgo_Mwnm3WSe7B-V850PshkTXl9jz6W91K3cbuSS1v-WNkQ025ry0VXLoLptVPelmpX3gQT08p6FyawdKGc9z71bZa47TcyHGl0r4uXjfSdfTPuV8Wvrzc_57eTu-_fFvPZ3UTTGqWJbjjXKs8NK6glalRDQcMYw6aCEFS1rpVUFiigGEMQm4YrhDlr8r0lGht8Vbzf62597MRoVCcgJxBWtGYgE4s9YaJci23rNrLdiSideCzEdilkm5z2VtREIco0sgZJohujKCAaUGwxrw1WOmt9GV_r1cYabUNqpT8RPb0JbiWW8UHk3yBe4SxwPQq08XdvuyQ2rtPWexls7B_npgQSgsl_oLhmmFI-oB-eoM8bMVJLmf_qQhPziHoQFTPCIKeYI56p6TNUXsZunM4BbFyunzS8O_bkrxmH4GXg8x7I4ei61jZCu5RTGAeLnBcQiCHlh5nFkHIxpjw3kyfNB_1_tv0B9ZQCiQ
CitedBy_id crossref_primary_10_1016_j_colsurfb_2017_04_039
crossref_primary_10_1002_jor_25564
crossref_primary_10_1016_j_jmii_2020_07_022
crossref_primary_10_3389_fimmu_2023_1174249
crossref_primary_10_1016_j_intimp_2021_108083
crossref_primary_10_1093_ibd_izae155
crossref_primary_10_1016_j_tube_2020_102039
crossref_primary_10_1080_1744666X_2019_1614915
crossref_primary_10_3390_nu11071688
crossref_primary_10_1007_s10565_021_09652_7
crossref_primary_10_1016_j_taap_2021_115470
crossref_primary_10_1016_j_lungcan_2018_07_015
crossref_primary_10_1038_s41419_019_1656_4
crossref_primary_10_3389_fimmu_2019_02874
crossref_primary_10_1016_j_intimp_2022_108907
crossref_primary_10_1016_j_neo_2019_11_001
crossref_primary_10_1016_j_autrev_2019_102397
crossref_primary_10_1371_journal_pone_0175238
crossref_primary_10_1016_j_virusres_2020_197991
crossref_primary_10_1007_s43032_022_00890_6
crossref_primary_10_1099_jmm_0_000496
crossref_primary_10_1016_j_intimp_2022_109089
crossref_primary_10_3390_ijms19113562
crossref_primary_10_3389_fimmu_2024_1534823
crossref_primary_10_3390_ijms22031064
crossref_primary_10_1111_pcmr_13002
crossref_primary_10_3390_pathogens8040280
crossref_primary_10_1186_s12974_018_1164_y
crossref_primary_10_1111_exd_70014
crossref_primary_10_3390_ph16040569
crossref_primary_10_1002_hep_29346
crossref_primary_10_3389_fimmu_2020_01167
crossref_primary_10_1165_rcmb_2021_0504OC
crossref_primary_10_1016_j_autrev_2017_05_024
crossref_primary_10_3389_fimmu_2019_01858
crossref_primary_10_3390_ijms23052509
crossref_primary_10_1177_10406387211053254
crossref_primary_10_3390_genes12030445
crossref_primary_10_1016_j_cellimm_2018_07_008
crossref_primary_10_1016_j_ebiom_2019_01_067
crossref_primary_10_3389_fimmu_2017_01242
crossref_primary_10_3389_fimmu_2017_00693
crossref_primary_10_1038_s41537_017_0042_4
crossref_primary_10_1002_art_42061
crossref_primary_10_3389_fimmu_2022_936995
Cites_doi 10.1055/s-0030-1255354
10.1016/j.immuni.2014.06.010
10.1038/labinvest.2010.73
10.1038/nrrheum.2015.111
10.1016/j.jaut.2009.09.012
10.1371/journal.pgen.1003291
10.1371/journal.pone.0118010
10.1152/ajprenal.00421.2006
10.3899/jrheum.081030
10.1186/s13098-015-0108-2
10.1016/j.clinre.2015.09.005
10.1371/journal.pone.0081382
10.1038/labinvest.2013.69
10.1111/j.1600-0625.2008.00828.x
10.1038/nri2448
10.1186/s12885-015-1546-9
10.1016/j.clim.2010.06.017
10.1016/j.immuni.2014.06.008
10.1038/nature12034
10.1016/j.jdermsci.2016.05.015
10.1016/j.febslet.2009.04.027
10.1016/S1471-4906(02)02302-5
10.1186/ar3066
10.1016/S1499-3872(14)60261-7
10.1038/nm.2807
10.1164/rccm.200509-1518OC
10.1111/exd.12727
10.1093/hmg/ddn376
10.1016/j.canlet.2014.05.008
10.1002/art.30318
10.1016/j.imbio.2005.05.010
10.1006/meth.2001.1262
10.1152/ajplung.00474.2004
10.1007/s11926-015-0554-8
10.1038/nri3073
10.1016/j.jim.2007.10.003
10.1007/s12026-012-8291-9
10.3899/jrheum.150088
10.1164/rccm.201010-1719OC
10.1038/labinvest.2013.3
10.3899/jrheum.141070
10.5527/wjn.v2.i3.84
10.1002/path.4133
10.1371/journal.pone.0149276
10.3389/fphar.2012.00119
10.1189/jlb.1012512
10.1111/acel.12350
ContentType Journal Article
Copyright COPYRIGHT 2016 Public Library of Science
2016 Soldano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2016 Soldano et al 2016 Soldano et al
Copyright_xml – notice: COPYRIGHT 2016 Public Library of Science
– notice: 2016 Soldano et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2016 Soldano et al 2016 Soldano et al
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QG
7QL
7QO
7RV
7SN
7SS
7T5
7TG
7TM
7U9
7X2
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FG
8FH
8FI
8FJ
8FK
ABJCF
ABUWG
AEUYN
AFKRA
ARAPS
ATCPS
AZQEC
BBNVY
BENPR
BGLVJ
BHPHI
C1K
CCPQU
D1I
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB.
KB0
KL.
L6V
LK8
M0K
M0S
M1P
M7N
M7P
M7S
NAPCQ
P5Z
P62
P64
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
PTHSS
PYCSY
RC3
7X8
5PM
DOA
DOI 10.1371/journal.pone.0166433
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Animal Behavior Abstracts
Bacteriology Abstracts (Microbiology B)
Biotechnology Research Abstracts
ProQuest Nursing & Allied Health Database
Ecology Abstracts
Entomology Abstracts (Full archive)
Immunology Abstracts
Meteorological & Geoastrophysical Abstracts
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Proquest Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Technology Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Materials Science & Engineering
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
Advanced Technologies & Aerospace Collection
Agricultural & Environmental Science Collection
ProQuest Central Essentials
Biological Science Database
ProQuest Central
Technology Collection (via ProQuest SciTech Premium Collection)
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Materials Science Collection
ProQuest Central Korea
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Materials Science Database (Proquest)
Nursing & Allied Health Database (Alumni Edition)
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest Engineering Collection
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Biological Science
Engineering Database (Proquest)
Nursing & Allied Health Premium
ProQuest advanced technologies & aerospace journals
ProQuest Advanced Technologies & Aerospace Collection
Biotechnology and BioEngineering Abstracts
Environmental Science Database
Materials Science Collection
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Engineering collection
Environmental Science Collection
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
Publicly Available Content Database
ProQuest Central Student
ProQuest Advanced Technologies & Aerospace Collection
ProQuest Central Essentials
Nucleic Acids Abstracts
SciTech Premium Collection
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
Health Research Premium Collection
Meteorological & Geoastrophysical Abstracts
Natural Science Collection
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
Engineering Collection
Advanced Technologies & Aerospace Collection
Engineering Database
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
ProQuest Technology Collection
Health Research Premium Collection (Alumni)
Biological Science Database
Ecology Abstracts
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Environmental Science Collection
Entomology Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
Environmental Science Database
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
Meteorological & Geoastrophysical Abstracts - Academic
ProQuest One Academic (New)
Technology Collection
Technology Research Database
ProQuest One Academic Middle East (New)
Materials Science Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central
ProQuest Health & Medical Research Collection
Genetics Abstracts
ProQuest Engineering Collection
Biotechnology Research Abstracts
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Agricultural & Environmental Science Collection
AIDS and Cancer Research Abstracts
Materials Science Database
ProQuest Materials Science Collection
ProQuest Public Health
ProQuest Nursing & Allied Health Source
ProQuest SciTech Collection
Advanced Technologies & Aerospace Database
ProQuest Medical Library
Animal Behavior Abstracts
Materials Science & Engineering Collection
Immunology Abstracts
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE - Academic




Agricultural Science Database
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: 8FG
  name: ProQuest Technology Collection
  url: https://search.proquest.com/technologycollection1
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Sciences (General)
Medicine
DocumentTitleAlternate Endothelin-1 Effects on Cultured Macrophages
EISSN 1932-6203
ExternalDocumentID 1841156970
oai_doaj_org_article_94b267c2ed2a4cfdb604c063e389d3bc
PMC5112853
4254121321
A471863828
27846260
10_1371_journal_pone_0166433
Genre Journal Article
GeographicLocations Italy
GeographicLocations_xml – name: Italy
GroupedDBID ---
123
29O
2WC
53G
5VS
7RV
7X2
7X7
7XC
88E
8AO
8C1
8CJ
8FE
8FG
8FH
8FI
8FJ
A8Z
AAFWJ
AAUCC
AAWOE
AAYXX
ABDBF
ABIVO
ABJCF
ABUWG
ACGFO
ACIHN
ACIWK
ACPRK
ACUHS
ADBBV
ADRAZ
AEAQA
AENEX
AEUYN
AFKRA
AFPKN
AFRAH
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
APEBS
ARAPS
ATCPS
BAWUL
BBNVY
BCNDV
BENPR
BGLVJ
BHPHI
BKEYQ
BPHCQ
BVXVI
BWKFM
CCPQU
CITATION
CS3
D1I
D1J
D1K
DIK
DU5
E3Z
EAP
EAS
EBD
EMOBN
ESX
EX3
F5P
FPL
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
IAO
IEA
IGS
IHR
IHW
INH
INR
IOV
IPY
ISE
ISR
ITC
K6-
KB.
KQ8
L6V
LK5
LK8
M0K
M1P
M48
M7P
M7R
M7S
M~E
NAPCQ
O5R
O5S
OK1
OVT
P2P
P62
PATMY
PDBOC
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
PTHSS
PV9
PYCSY
RNS
RPM
RZL
SV3
TR2
UKHRP
WOQ
WOW
~02
~KM
BBORY
CGR
CUY
CVF
ECM
EIF
IPNFZ
NPM
RIG
PMFND
3V.
7QG
7QL
7QO
7SN
7SS
7T5
7TG
7TM
7U9
7XB
8FD
8FK
AZQEC
C1K
DWQXO
FR3
GNUQQ
H94
K9.
KL.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
RC3
7X8
ESTFP
PUEGO
5PM
AAPBV
ABPTK
ID FETCH-LOGICAL-c692t-cf88cb620151ca2fbf60f7773d511059c9babe0b0b77213df8b2387f3d5e4c3d3
IEDL.DBID DOA
ISSN 1932-6203
IngestDate Sun Sep 03 00:14:19 EDT 2023
Wed Aug 27 01:23:58 EDT 2025
Thu Aug 21 13:49:29 EDT 2025
Sun Sep 28 14:48:31 EDT 2025
Mon Sep 08 04:17:13 EDT 2025
Fri Jul 25 10:20:32 EDT 2025
Tue Jun 17 20:49:40 EDT 2025
Tue Jun 10 20:36:08 EDT 2025
Thu Apr 03 07:08:46 EDT 2025
Tue Jul 01 01:05:14 EDT 2025
Thu Apr 24 22:58:56 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Creative Commons Attribution License
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c692t-cf88cb620151ca2fbf60f7773d511059c9babe0b0b77213df8b2387f3d5e4c3d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: The authors have declared that no competing interests exist.
Conceptualization: SS MC.Data curation: SS PM RB.Formal analysis: SS ACT PM RB.Investigation: SS.Methodology: SS PM RB.Project administration: SS.Resources: CP SP BR AS.Software: ACT.Supervision: MC.Validation: MC.Visualization: MC.Writing – original draft: SS MC.Writing – review & editing: CP SP BR AS.
OpenAccessLink https://doaj.org/article/94b267c2ed2a4cfdb604c063e389d3bc
PMID 27846260
PQID 1841156970
PQPubID 1436336
ParticipantIDs plos_journals_1841156970
doaj_primary_oai_doaj_org_article_94b267c2ed2a4cfdb604c063e389d3bc
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5112853
proquest_miscellaneous_1846414434
proquest_miscellaneous_1839736684
proquest_journals_1841156970
gale_infotracmisc_A471863828
gale_infotracacademiconefile_A471863828
pubmed_primary_27846260
crossref_citationtrail_10_1371_journal_pone_0166433
crossref_primary_10_1371_journal_pone_0166433
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-11-15
PublicationDateYYYYMMDD 2016-11-15
PublicationDate_xml – month: 11
  year: 2016
  text: 2016-11-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: San Francisco
– name: San Francisco, CA USA
PublicationTitle PloS one
PublicationTitleAlternate PLoS One
PublicationYear 2016
Publisher Public Library of Science
Public Library of Science (PLoS)
Publisher_xml – name: Public Library of Science
– name: Public Library of Science (PLoS)
References M Cutolo (ref24) 2013; 31
MA Gibbons (ref27) 2011; 184
KT Tan (ref49) 2013; 93
E Tinazzi (ref15) 2015; 2015
M Novak (ref34) 2013; 93
PJ Murray (ref5) 2011; 11
JM Catania (ref50) 2007; 292
CY Liu (ref40) 2013; 93
G Stifano (ref4) 2016; 18
QM Fan (ref45) 2014; 352
CA Beamer (ref28) 2005; 289
KJ Livak (ref22) 2001; 25
JA Araujo (ref19) 2012; 3
R Noy (ref43) 2014; 41
TA Wynn (ref7) 2012; 18
SK Biswas (ref3) 2012; 53
RB Christmann (ref32) 2011; 63
M Cutolo (ref51) 2015; 11
D Fairweather (ref8) 2009; 33
M Manetti (ref37) 2015; 24
SK Mathai (ref29) 2010; 90
BO Fabriek (ref31) 2005; 210
H Zhao (ref44) 2013; 2
J Kurzepa (ref47) 2014; 13
M Genin (ref17) 2015; 15
M Cutolo (ref14) 2015; 42
Y Wang (ref35) 2015; 14
T Fujimura (ref42) 2016; 83
A Mantovani (ref41) 2002; 23
M Stahl (ref26) 2013; 8
DM Mosser (ref6) 2008; 8
O Hashimoto (ref20) 2016
A Sulli (ref11) 2009; 36
N Higashi-Kuwata (ref9) 2010; 12
CL Lino Cardenas (ref46) 2013; 9
TA Wynn (ref2) 2013; 496
DV Pechkovsky (ref33) 2010; 137
A Prasse (ref30) 2006; 173
JY Park (ref39) 2016; 40
PJ Murray (ref21) 2014; 41
ME Tulapurkar (ref23) 2015; 10
N Higashi-Kuwata (ref10) 2009; 18
TA Wynn (ref48) 2010; 30
P Cipriani (ref13) 2015; 42
A Mantovani (ref1) 2013; 229
C Dumrese (ref25) 2009; 583
M Shigeoka (ref38) 2013; 104
GM Gersuk (ref18) 2008; 329
AP Yu (ref12) 2015; 7
C Barisone (ref16) 2016; 11
SA Villalta (ref36) 2009; 18
26253167 - BMC Cancer. 2015 Aug 08;15:577
22418728 - Immunol Res. 2012 Sep;53(1-3):11-24
25475858 - Hepatobiliary Pancreat Dis Int. 2014 Dec;13(6):570-9
23459460 - PLoS Genet. 2013;9(2):e1003291
28358878 - PLoS One. 2017 Mar 30;12 (3):e0175238
19320738 - Exp Dermatol. 2009 Aug;18(8):727-9
21425123 - Arthritis Rheum. 2011 Jun;63(6):1718-28
26090478 - J Immunol Res. 2015;2015:147616
23358111 - Lab Invest. 2013 Apr;93(4):434-49
24295474 - Clin Exp Rheumatol. 2013 Nov-Dec;31(6):943-6
20404807 - Lab Invest. 2010 Jun;90(6):812-23
23505314 - J Leukoc Biol. 2013 Jun;93(6):875-81
26260763 - Nat Rev Rheumatol. 2015 Oct;11(10):569-71
24892648 - Cancer Lett. 2014 Oct 1;352(2):160-8
23752129 - Lab Invest. 2013 Jul;93(7):844-54
22833723 - Front Pharmacol. 2012 Jul 19;3:119
26700912 - Curr Rheumatol Rep. 2016 Jan;18(1):2
19819674 - J Autoimmun. 2009 Nov-Dec;33(3-4):222-30
18996917 - Hum Mol Genet. 2009 Feb 1;18(3):482-96
20674506 - Clin Immunol. 2010 Oct;137(1):89-101
24278429 - PLoS One. 2013 Nov 20;8(11):e81382
27425378 - J Pathol. 2016 Oct;240(2):211-23
25593238 - J Rheumatol. 2015 Mar;42(3):456-63
25869115 - Exp Dermatol. 2015 Aug;24(8):576-8
21997792 - Nat Rev Immunol. 2011 Oct 14;11(11):723-37
20665377 - Semin Liver Dis. 2010 Aug;30(3):245-57
26508473 - Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):357-65
27291068 - J Dermatol Sci. 2016 Sep;83(3):167-73
16415274 - Am J Respir Crit Care Med. 2006 Apr 1;173(7):781-92
19369451 - J Rheumatol. 2009 Jun;36(6):1235-9
19029990 - Nat Rev Immunol. 2008 Dec;8(12):958-69
24255890 - World J Nephrol. 2013 Aug 6;2(3):84-9
17997408 - J Immunol Methods. 2008 Jan 1;329(1-2):157-66
21680953 - Am J Respir Crit Care Med. 2011 Sep 1;184(5):569-81
25659128 - PLoS One. 2015 Feb 06;10(2):e0118010
11846609 - Methods. 2001 Dec;25(4):402-8
26276964 - J Rheumatol. 2015 Oct;42(10):1808-16
19393649 - FEBS Lett. 2009 May 19;583(10):1637-43
12401408 - Trends Immunol. 2002 Nov;23(11):549-55
17190907 - Am J Physiol Renal Physiol. 2007 Mar;292(3):F905-11
16164022 - Immunobiology. 2005;210(2-4):153-60
25035953 - Immunity. 2014 Jul 17;41(1):49-61
15849212 - Am J Physiol Lung Cell Mol Physiol. 2005 Aug;289(2):L186-95
25035950 - Immunity. 2014 Jul 17;41(1):14-20
26692905 - Diabetol Metab Syndr. 2015 Dec 10;7:111
23648122 - Cancer Sci. 2013 Aug;104(8):1112-9
26009878 - Aging Cell. 2015 Aug;14(4):678-88
23619691 - Nature. 2013 Apr 25;496(7446):445-55
26925780 - PLoS One. 2016 Feb 29;11(2):e0149276
20602758 - Arthritis Res Ther. 2010;12(4):R128
23096265 - J Pathol. 2013 Jan;229(2):176-85
22772564 - Nat Med. 2012 Jul 06;18(7):1028-40
References_xml – volume: 30
  start-page: 245
  year: 2010
  ident: ref48
  article-title: Macrophages: master regulators of inflammation and fibrosis
  publication-title: Semin Liver Dis
  doi: 10.1055/s-0030-1255354
– volume: 41
  start-page: 49
  year: 2014
  ident: ref43
  article-title: Tumor-associated macrophages: from mechanisms to therapy
  publication-title: Immunity
  doi: 10.1016/j.immuni.2014.06.010
– volume: 90
  start-page: 812
  year: 2010
  ident: ref29
  article-title: Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype
  publication-title: Laboratory Investigation
  doi: 10.1038/labinvest.2010.73
– volume: 11
  start-page: 569
  year: 2015
  ident: ref51
  article-title: Therapy. Optimized treatment algorithms for digital vasculopathy in SSc
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2015.111
– volume: 33
  start-page: 222
  year: 2009
  ident: ref8
  article-title: Alternatively activated macrophages in infection and autoimmunity
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2009.09.012
– volume: 9
  start-page: e1003291
  year: 2013
  ident: ref46
  article-title: miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1
  publication-title: PLoS Genet
  doi: 10.1371/journal.pgen.1003291
– volume: 10
  start-page: e0118010
  year: 2015
  ident: ref23
  article-title: Bacterial lipopolysaccharide augments febrile-range hyperthermia-induced heat shock protein 70 expression and extracellular release in human THP1 cells
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0118010
– volume: 292
  start-page: 905
  year: 2007
  ident: ref50
  article-title: Role of matrix metalloproteinases in renal pathophysiologies
  publication-title: Am J Physiol Renal Physiol
  doi: 10.1152/ajprenal.00421.2006
– volume: 104
  start-page: 1112
  year: 2013
  ident: ref38
  article-title: Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma
  publication-title: Cancer Cel
– volume: 36
  start-page: 1235
  year: 2009
  ident: ref11
  article-title: Raynaud's phenomenon and plasma endothelin: correlations with capillaroscopic patterns in systemic sclerosis
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.081030
– volume: 7
  start-page: 111
  year: 2015
  ident: ref12
  article-title: Association of endothelin-1 and matrix metallopeptidase-9 with metabolic syndrome in middle-aged and older adults
  publication-title: Diabetol Metab Syndr
  doi: 10.1186/s13098-015-0108-2
– volume: 40
  start-page: 357
  year: 2016
  ident: ref39
  article-title: Polarized CD163+tumor-associated macrophages are associated with increased angiogenesis and CXCL12 expression in gastric cancer
  publication-title: Clin Res Hepatol Gastroenterol
  doi: 10.1016/j.clinre.2015.09.005
– volume: 8
  start-page: e81382
  year: 2013
  ident: ref26
  article-title: Lung collagens perpetuate pulmonary fibrosis via CD204 and M2 macrophage activation
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0081382
– volume: 93
  start-page: 844
  year: 2013
  ident: ref40
  article-title: M2-polarized tumor-associated macrophages promoted epithelial-mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway
  publication-title: Lab Invest
  doi: 10.1038/labinvest.2013.69
– volume: 18
  start-page: 727
  year: 2009
  ident: ref10
  article-title: Alternatively activated macrophages (M2 macrophages) in the skin of patient with localized scleroderma
  publication-title: Exp Dermatol
  doi: 10.1111/j.1600-0625.2008.00828.x
– volume: 8
  start-page: 958
  year: 2008
  ident: ref6
  article-title: Exploring the full spectrum of macrophage activation
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri2448
– volume: 15
  start-page: 577
  year: 2015
  ident: ref17
  article-title: M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide
  publication-title: BMC Cancer
  doi: 10.1186/s12885-015-1546-9
– volume: 31
  start-page: 943
  year: 2013
  ident: ref24
  article-title: Intracellular NF-kB-decrease and IKBα increase in human macrophages following CTLA4-Ig treatment
  publication-title: Clin Exp Rheumatol
– volume: 137
  start-page: 89
  year: 2010
  ident: ref33
  article-title: Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2010.06.017
– volume: 41
  start-page: 14
  year: 2014
  ident: ref21
  article-title: Macrophage activation and polarization: nomenclature and experimental guidelines
  publication-title: Immunity
  doi: 10.1016/j.immuni.2014.06.008
– volume: 496
  start-page: 445
  year: 2013
  ident: ref2
  article-title: Macrophage biology in development, homeostasis and disease
  publication-title: Nature
  doi: 10.1038/nature12034
– volume: 83
  start-page: 167
  year: 2016
  ident: ref42
  article-title: Tumor-associated macrophages in skin: how to treat their heterogeneity and plasticity
  publication-title: J Dermatol Sci
  doi: 10.1016/j.jdermsci.2016.05.015
– volume: 583
  start-page: 1637
  year: 2009
  ident: ref25
  article-title: The secreted Helicobacter cysteine-rich protein A causes adherence of human monocytes and differentiation into a macrophage-like phenotype
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2009.04.027
– volume: 23
  start-page: 549
  year: 2002
  ident: ref41
  article-title: Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
  publication-title: Trends Immunol
  doi: 10.1016/S1471-4906(02)02302-5
– volume: 12
  start-page: R128
  year: 2010
  ident: ref9
  article-title: Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3066
– volume: 13
  start-page: 570
  year: 2014
  ident: ref47
  article-title: Role of MMP-2 and MMP-9 and their natural inhibitors in liver fibrosis, chronic pancreatitis and non-specific inflammatory bowel diseases
  publication-title: Hepatobiliary Pancreat Dis Int
  doi: 10.1016/S1499-3872(14)60261-7
– volume: 18
  start-page: 1028
  year: 2012
  ident: ref7
  article-title: Mechanisms of fibrosis: therapeutic translation for fibrotic disease
  publication-title: Nat Med
  doi: 10.1038/nm.2807
– volume: 173
  start-page: 781
  year: 2006
  ident: ref30
  article-title: A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.200509-1518OC
– volume: 24
  start-page: 576
  year: 2015
  ident: ref37
  article-title: Deciphering the alternatively activated (M2) phenotype of macrophages in scleroderma
  publication-title: Exp Dermatol
  doi: 10.1111/exd.12727
– volume: 18
  start-page: 482
  year: 2009
  ident: ref36
  article-title: Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy
  publication-title: Hum. Mol. Genet
  doi: 10.1093/hmg/ddn376
– volume: 352
  start-page: 160
  year: 2014
  ident: ref45
  article-title: Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2014.05.008
– volume: 63
  start-page: 1718
  year: 2011
  ident: ref32
  article-title: Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertension
  publication-title: Arthritis Rheum
  doi: 10.1002/art.30318
– volume: 210
  start-page: 153
  year: 2005
  ident: ref31
  article-title: The macrophage scavenger receptor CD163
  publication-title: Immunobiology
  doi: 10.1016/j.imbio.2005.05.010
– volume: 25
  start-page: 402
  year: 2001
  ident: ref22
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
  publication-title: Method
  doi: 10.1006/meth.2001.1262
– volume: 289
  start-page: 186
  year: 2005
  ident: ref28
  article-title: Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00474.2004
– volume: 18
  start-page: 2
  year: 2016
  ident: ref4
  article-title: Macrophage involvement in systemic sclerosis: do we need more evidence?
  publication-title: Curr Rheumatol Rep
  doi: 10.1007/s11926-015-0554-8
– volume: 11
  start-page: 723
  year: 2011
  ident: ref5
  article-title: Protective and pathogenic functions of macrophage subsets
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3073
– volume: 329
  start-page: 157
  year: 2008
  ident: ref18
  article-title: Methods of in vitro macrophage maturation confer variable inflammatory responses in association with altered expression of cell surface dectin-1
  publication-title: J Immunol Methods
  doi: 10.1016/j.jim.2007.10.003
– volume: 53
  start-page: 11
  year: 2012
  ident: ref3
  article-title: Macrophage polarization and plasticity in health and disease
  publication-title: Immunol Res
  doi: 10.1007/s12026-012-8291-9
– volume: 42
  start-page: 1808
  year: 2015
  ident: ref13
  article-title: The endothelial-mesenchymal transition in systemic sclerosis is induced by endothelin-1 and transforming growth factor-beta and may be blocked by macitentan, a dual endothelin-1 receptor antagonist
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.150088
– volume: 184
  start-page: 569
  year: 2011
  ident: ref27
  article-title: Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201010-1719OC
– volume: 93
  start-page: 434
  year: 2013
  ident: ref49
  article-title: Matrix metalloproteinase-9 of tubular and macrophages origin contributes to the pathogenesis of renal fibrosis via macrophage recruitment through osteopontin
  publication-title: Lab Invest
  doi: 10.1038/labinvest.2013.3
– year: 2016
  ident: ref20
  article-title: Collaboration of cancer-associated fibroblasts and tumour-associated macrophages for neuroblastoma development
  publication-title: J Pathol
– volume: 42
  start-page: 456
  year: 2015
  ident: ref14
  article-title: Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.141070
– volume: 2
  start-page: 84
  year: 2013
  ident: ref44
  article-title: Matrix metalloproteinases contribute to kidney fibrosis in chronic kidney diseases
  publication-title: World J Nephrol
  doi: 10.5527/wjn.v2.i3.84
– volume: 2015
  start-page: 147616
  year: 2015
  ident: ref15
  article-title: Endothelin receptors expressed by immune cells are involved in modulation of inflammation and in fibrosis: relevance to the pathogenesis of systemic sclerosis
  publication-title: J Immunol Res
– volume: 229
  start-page: 176
  year: 2013
  ident: ref1
  article-title: Macrophage plasticity and polarization in tissue repair and remodelling
  publication-title: J Pathol
  doi: 10.1002/path.4133
– volume: 11
  start-page: e0149276
  year: 2016
  ident: ref16
  article-title: Moderate increase of indoxyl sulfate promotes monocyte transition into profibrotic macrophages
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0149276
– volume: 3
  start-page: 119
  year: 2012
  ident: ref19
  article-title: Heme oxygenase-1, oxidation, inflammation and atherosclerosis
  publication-title: Front Pharmacol
  doi: 10.3389/fphar.2012.00119
– volume: 93
  start-page: 875
  year: 2013
  ident: ref34
  article-title: Macrophage phenotypes during tissue repair
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.1012512
– volume: 14
  start-page: 678
  year: 2015
  ident: ref35
  article-title: Increases of M2a macrophages and fibrosis in aging muscle are influenced by bone marrow aging and negatively regulated by muscle-derived nitric oxide
  publication-title: Aging Cell
  doi: 10.1111/acel.12350
– reference: 17997408 - J Immunol Methods. 2008 Jan 1;329(1-2):157-66
– reference: 27291068 - J Dermatol Sci. 2016 Sep;83(3):167-73
– reference: 20404807 - Lab Invest. 2010 Jun;90(6):812-23
– reference: 27425378 - J Pathol. 2016 Oct;240(2):211-23
– reference: 20674506 - Clin Immunol. 2010 Oct;137(1):89-101
– reference: 25659128 - PLoS One. 2015 Feb 06;10(2):e0118010
– reference: 26925780 - PLoS One. 2016 Feb 29;11(2):e0149276
– reference: 20602758 - Arthritis Res Ther. 2010;12(4):R128
– reference: 21425123 - Arthritis Rheum. 2011 Jun;63(6):1718-28
– reference: 26253167 - BMC Cancer. 2015 Aug 08;15:577
– reference: 15849212 - Am J Physiol Lung Cell Mol Physiol. 2005 Aug;289(2):L186-95
– reference: 19369451 - J Rheumatol. 2009 Jun;36(6):1235-9
– reference: 19393649 - FEBS Lett. 2009 May 19;583(10):1637-43
– reference: 24255890 - World J Nephrol. 2013 Aug 6;2(3):84-9
– reference: 21680953 - Am J Respir Crit Care Med. 2011 Sep 1;184(5):569-81
– reference: 22418728 - Immunol Res. 2012 Sep;53(1-3):11-24
– reference: 21997792 - Nat Rev Immunol. 2011 Oct 14;11(11):723-37
– reference: 23648122 - Cancer Sci. 2013 Aug;104(8):1112-9
– reference: 22833723 - Front Pharmacol. 2012 Jul 19;3:119
– reference: 24278429 - PLoS One. 2013 Nov 20;8(11):e81382
– reference: 23619691 - Nature. 2013 Apr 25;496(7446):445-55
– reference: 19029990 - Nat Rev Immunol. 2008 Dec;8(12):958-69
– reference: 25035953 - Immunity. 2014 Jul 17;41(1):49-61
– reference: 26692905 - Diabetol Metab Syndr. 2015 Dec 10;7:111
– reference: 24892648 - Cancer Lett. 2014 Oct 1;352(2):160-8
– reference: 20665377 - Semin Liver Dis. 2010 Aug;30(3):245-57
– reference: 16164022 - Immunobiology. 2005;210(2-4):153-60
– reference: 24295474 - Clin Exp Rheumatol. 2013 Nov-Dec;31(6):943-6
– reference: 17190907 - Am J Physiol Renal Physiol. 2007 Mar;292(3):F905-11
– reference: 19819674 - J Autoimmun. 2009 Nov-Dec;33(3-4):222-30
– reference: 26260763 - Nat Rev Rheumatol. 2015 Oct;11(10):569-71
– reference: 12401408 - Trends Immunol. 2002 Nov;23(11):549-55
– reference: 25475858 - Hepatobiliary Pancreat Dis Int. 2014 Dec;13(6):570-9
– reference: 25035950 - Immunity. 2014 Jul 17;41(1):14-20
– reference: 26090478 - J Immunol Res. 2015;2015:147616
– reference: 23459460 - PLoS Genet. 2013;9(2):e1003291
– reference: 26508473 - Clin Res Hepatol Gastroenterol. 2016 Jun;40(3):357-65
– reference: 25869115 - Exp Dermatol. 2015 Aug;24(8):576-8
– reference: 25593238 - J Rheumatol. 2015 Mar;42(3):456-63
– reference: 19320738 - Exp Dermatol. 2009 Aug;18(8):727-9
– reference: 11846609 - Methods. 2001 Dec;25(4):402-8
– reference: 23505314 - J Leukoc Biol. 2013 Jun;93(6):875-81
– reference: 18996917 - Hum Mol Genet. 2009 Feb 1;18(3):482-96
– reference: 16415274 - Am J Respir Crit Care Med. 2006 Apr 1;173(7):781-92
– reference: 23358111 - Lab Invest. 2013 Apr;93(4):434-49
– reference: 26276964 - J Rheumatol. 2015 Oct;42(10):1808-16
– reference: 28358878 - PLoS One. 2017 Mar 30;12 (3):e0175238
– reference: 23096265 - J Pathol. 2013 Jan;229(2):176-85
– reference: 26700912 - Curr Rheumatol Rep. 2016 Jan;18(1):2
– reference: 22772564 - Nat Med. 2012 Jul 06;18(7):1028-40
– reference: 23752129 - Lab Invest. 2013 Jul;93(7):844-54
– reference: 26009878 - Aging Cell. 2015 Aug;14(4):678-88
SSID ssj0053866
Score 2.441359
Snippet Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204...
Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger...
Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger...
SourceID plos
doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage e0166433
SubjectTerms 12-O-Tetradecanoylphorbol-13-acetate
Acetic acid
Aging
Antigens, CD - genetics
Antigens, CD - immunology
Antigens, Differentiation, Myelomonocytic - genetics
Antigens, Differentiation, Myelomonocytic - immunology
Biology and Life Sciences
Cancer therapies
CD163 antigen
Cell Differentiation - drug effects
Cell Line
Chemokine CCL22 - genetics
Chemokine CCL22 - immunology
Cytokines
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Endothelin
Endothelin 1
Endothelin Receptor Antagonists - pharmacology
Endothelin-1 - pharmacology
Fibrosis
Gelatinase B
Gene expression
Gene Expression Regulation
Genes
Genetic aspects
Genotype & phenotype
Growth factors
Humans
Immunocytochemistry
Interleukin 10
Interleukin 4
Interleukin-10 - genetics
Interleukin-10 - immunology
Interleukin-4 - pharmacology
Interleukins
Internal medicine
Laboratories
Lectins, C-Type - genetics
Lectins, C-Type - immunology
Macrophage Activation - drug effects
Macrophages
Macrophages - cytology
Macrophages - drug effects
Macrophages - immunology
Mannose
Mannose-Binding Lectins - genetics
Mannose-Binding Lectins - immunology
Markers
Matrix Metalloproteinase 9 - genetics
Matrix Metalloproteinase 9 - immunology
Medicine
Medicine and Health Sciences
Metalloproteinase
Monocytes
Monocytes - cytology
Monocytes - drug effects
Monocytes - immunology
Monosaccharides
Pathogenesis
Peripheral blood
Phenotype
Polymerase chain reaction
Primary Cell Culture
Receptor, Endothelin A - genetics
Receptor, Endothelin A - immunology
Receptors
Receptors, Cell Surface - genetics
Receptors, Cell Surface - immunology
Research and Analysis Methods
Rheumatology
Scavenger receptors
Scavenger Receptors, Class A - genetics
Scavenger Receptors, Class A - immunology
Scleroderma (Disease)
Studies
Sulfonamides - pharmacology
Systemic sclerosis
Tetradecanoylphorbol Acetate - pharmacology
Transforming Growth Factor beta1 - genetics
Transforming Growth Factor beta1 - immunology
Transforming growth factor-b1
Transforming growth factors
Type 2 diabetes
Western blotting
SummonAdditionalLinks – databaseName: ProQuest Technology Collection
  dbid: 8FG
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELZgkRAXRMujgYKMhER7SJvYjp2c0IK6FKRFHKjUWxQ_wq4UJUuzrdR_35nECQ2qynU98VrjeXz2eGYI-ZBwlkohZagLkYVCySTUieJh7DJmHbPMdRX4lj_k6Zn4fp6c-wu31j-rHGxiZ6htY_CO_BhOIgBeZKaiT5s_IXaNwuiqb6HxkDyKGUgSZoovvg6WGHRZSp8ux1V87HfnaNPU7gigDjhjPnFHXdX-0TbPNlXT3gU8_30_ecshLZ6Rpx5J0nm_9Tvkgat3yeOlj5Xvkh2vti098LWlD5-Tal75G8ArV13Tuem6mzlLD5bskC4LbOi1AhNDf65c3eD9LP3WUuzvYda6clRf05PaYtYWwNMwpuua9kU5YYouHnBrjvYFOVuc_PpyGvqGC6GRGduGpkxToyVggiQ2BSt1KaNSKcUtwDLAYSbThXaRjjRg8pjbMtXg8VUJ404YbvlLMquBuXuEgkcsMlsojGwL8IBZGSs4D0srnBQ6kgHhA99z46uRY1OMKu9CbApOJT0bc9yt3O9WQMLxq01fjeM_9J9xS0darKXd_dBc_M69auaZ0Ewqw5xlhTCl1TISBpCbAyxnuTYB-YgCkaPGwxJN4RMX4H-wdlY-R_8OwsfSgOxPKEFTzWR4D0VqWGmb_5Vp-HIQs7uH34_DOCk-jKtdc4k0ACi5lKm4j0ZIAQdnDjSveskdOYJxZzzTBkRNZHrCsulIvV51ZcgRqgPYe33_0t-QJyBPEtM342SfzLYXl-4t4Litftcp6w2MjUea
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELaWcuGCWF4bWJCRkNg9pEpsx04OCBW0qwWpiAOV9hbFj9BKUVqaLqL_npnEiTaowIVrZuxE4xnPN554hpDXCWepFFKGuhBZKJRMQp0oHsYuY9Yxy1xbgW_-WV4txKfr5PqI9D1bvQCbg6Ed9pNabKvpz-_7d2Dwb9uuDSruB00369pNAcKAk-V3yF3wTQz1fC6GvAJYt5T-At2fRo4cVFvHf9itJ5tq3RyCor__UXnLRV0-IPc9tqSzThmOyZGrH5Jjb70NPfMlps8fkWpW-YPAH67a05lpm5w5S8_m7JzOC-zrtYSdhn5ZunqNx7T0Y0OxzYdZ6cpRvacXtcXLW4BSw5iuatrV5oQp2rTArTmax2RxefH1w1Xo-y6ERmZsF5oyTY2WAA2S2BSs1KWMSqUUt4DOAI6ZTBfaRTrSAM1jbstUg-NXJdCdMNzyJ2RSg0RPCAXHWGS2UJjgFuAIszJWEBZLK5wUOpIB4b2wc-OLkmNvjCpvM20KgpNOdjkuUe6XKCDhMGrTFeX4B_97XMeBF0tqtw_W22-5t9A8E5pJZZizrBCmtFpGwgCAcwDpLNcmIG9QC3JURfhEU_j7C_AeLKGVz9DNw27G0oCcjjjBYM2IfIJ61H9pk0OQDbhcZiqCkb1uHSa_Gsg4Kf4fV7v1DfIAruRSpuJvPEIKiJ858Dzt1HWQCKafMbQNiBop8khkY0q9WrbVyBGxA-Z79j9k_JzcA62TeNczTk7JZLe9cS8A9O30y9aOfwH9t1eh
  priority: 102
  providerName: Scholars Portal
Title Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages
URI https://www.ncbi.nlm.nih.gov/pubmed/27846260
https://www.proquest.com/docview/1841156970
https://www.proquest.com/docview/1839736684
https://www.proquest.com/docview/1846414434
https://pubmed.ncbi.nlm.nih.gov/PMC5112853
https://doaj.org/article/94b267c2ed2a4cfdb604c063e389d3bc
http://dx.doi.org/10.1371/journal.pone.0166433
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVFSB
  databaseName: Free Full-Text Journals in Chemistry
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: HH5
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://abc-chemistry.org/
  providerName: ABC ChemistRy
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: KQ8
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: KQ8
  dateStart: 20061001
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: DOA
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: ABDBF
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: DIK
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: GX1
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M~E
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: RPM
  dateStart: 20060101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 7X7
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: BENPR
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Technology Collection
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 8FG
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/technologycollection1
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Public Health Database
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: 8C1
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/publichealth
  providerName: ProQuest
– providerCode: PRVFZP
  databaseName: Scholars Portal Journals: Open Access
  customDbUrl:
  eissn: 1932-6203
  dateEnd: 20250930
  omitProxy: true
  ssIdentifier: ssj0053866
  issn: 1932-6203
  databaseCode: M48
  dateStart: 20061201
  isFulltext: true
  titleUrlDefault: http://journals.scholarsportal.info
  providerName: Scholars Portal
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Na9swFBdbdtllrPuq1y5oMFh7cGtLsmQf05KsG6SUsUJuxvowCRgnzOmg_33fsxUTj7JedtEhelbE0_v4PX28R8iXhLNUCilDXYgsFEomoU4UD2OXMeuYZa7NwDe_lle34sciWeyV-sI7YV164I5x55nQTCrDnGWFMKXVMhIG_KoDT2u5Nmh9wY3tgqnOBoMWS-kfynEVn_t1Odusa3cGIAfcMB84ojZff2-VR5tq3TwGOf--ObnnimavySuPIemkm_sBeebqN-TAa2lDT3wq6dO3pJpUfsPvj6vu6cS0xcycpSdzdkrnBdbvWoJFoTdLV69xO5Z-byiW8zArXTmq7-m0tvhIC9BoGNNVTbscnDBEu_2_N0bzjtzOpr8ur0JfXyE0MmPb0JRparQECJDEpmClLmVUKqW4BRQGsMtkutAu0pEGCB5zW6YaHLwqod8Jwy1_T0Y1cPSQUHCARWYLhQfZAhxeVsYKwl9phZNCRzIgfMfs3Pjk41gDo8rbEzUFQUjHuxyXKPdLFJCw_2rTJd94gv4C17GnxdTZ7Q8gULkXqPwpgQrIV5SCHBUcpmgK_04B_gdTZeUTdOdgtVgakOMBJSimGXQfohztZtrkEEwD_paZiuDLnWw93v2578ZB8R5c7dZ3SAP4kUuZin_RCCkgTuZA86ET154jeMyMIWxA1ECQBywb9tSrZZt1HJE5YLuP_4PHR-QlSJ3EN51xckxG29937hOAu60ek-dqoaBNL2NsZ9_G5MXF9Prm57jVcGjnIn0AtZVSwA
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKIgEXRMujCwWMBKI9pE1sx04OCC3Qapd2Kw6t1FsaP8KuFCVLswXtn-I3MpPH0kVVOfWamTiWZzLzjceeIeRtyFkkhZSeTkXsCSVDT4eKe4GLmXXMMldX4Bsfy-Gp-HoWnq2R391dGDxW2dnE2lDb0uAe-R5EIgBeZKz8j7MfHnaNwuxq10KjUYtDt_gFIVv1YfQF5PuOsYP9k89Dr-0q4BkZs7lnsigyWoLjCwOTskxn0s-UUtwC9gCwYWKdaudrXwPwDLjNIg1uTWVAd8Jwy2HcO-Su4L7AWv3qbBngge2Qsr2ex1Ww12rD7qws3C5AK3D-fMX91V0Clr6gN8vL6jqg--95zSsO8OARedgiVzpoVG2drLlig9wbt7n5DbLemomKbre1rHcek3yQtzuOP12-oANTd1Nzlm6P2Q4dp9hAbAImjX6buKLE_WA6qij2EzFTnTuqF3S_sHhLDOCwF9BpQZsioDBEnX-4Mkb1hJzeiiiekl4Bi7tJKHjgNLapwky6AI8bZ4GC-Fta4aTQvuwT3q17Ytrq59iEI0_qlJ6CKKhZxgSllbTS6hNv-dasqf7xH_5PKNIlL9burh-UF9-T1hQksdBMKsOcZakwmdXSFwaQogPsaLk2ffIeFSJBCwNTNGl7UQK-g7W6kgHiCTCbLOqTrRVOsAxmhbyJKtXNtEr-_kPwZqdm15PfLMk4KB7EK1x5iTwAYLmUkbiJR0gBgToHnmeN5i5XBPPcGEP3iVrR6ZUlW6UU00ld9hxDAwCXz2-e-mtyf3gyPkqORseHL8gD0C2JV0eDcIv05heX7iVgyLl-Vf-4lJzftqX4A-LWhPI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGkSZeEBsfKwwwEojtIWtjO3bzgFBhq1ZGpz0wqW9Z_BFaqUrK0oH6r_HXcZe4ZUHTeNprfHEs-_K73_nsO0LeRpz1pJAy0KmIA6FkFOhI8SB0MbOOWeaqDHyjU3l8Lr6Mo_EG-b26C4PHKleYWAG1LQzukXfAEwHyImPV7WT-WMTZ4eDj_EeAFaQw0roqp1GryIlb_gL3rfwwPIS1fsfY4Ojb5-PAVxgIjIzZIjBZr2e0BCMYhSZlmc5kN1NKcQs8BIiHiXWqXVd3NZDQkNusp8HEqQzanTDccuj3HrmvuOB4nEyN184e4IiU_qoeV2HHa8bBvMjdAdAsIAK8YQqrigFru9Caz4ryJtL779nNa8Zw8Ig89CyW9mu12yIbLt8mmyMfp98mWx4ySrrn81rvPyaz_szvPv50syXtm6qymrN0b8T26SjFYmITgDd6NnF5gXvDdFhSrC1ipnrmqF7So9zijTGgxkFIpzmtE4JCF1Us4lof5RNyfidL8ZS0cpjcHULBGqexTRVG1QVY3zgLFfji0gonhe7KNuGreU-Mz4SOBTlmSRXeU-AR1dOY4GolfrXaJFi_Na8zgfxH_hMu6VoW83hXD4rL74mHhSQWmkllmLMsFSazWnaFAdbogEdark2bvEeFSBBtYIgm9Zcm4DuYtyvpI7cACGW9NtltSAJKmEbzDqrUaqRl8vd_gjdXanZz85t1M3aKh_JyV1yhDJBZLmVP3CYjpACnnYPMs1pz1zOCMW_0p9tENXS6MWXNlnw6qVKgo5sARPP57UN_TTYBI5Kvw9OTF-QBqJbEW6RhtEtai8sr9xLo5EK_qv5bSi7uGij-ACIMiS0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alternatively+Activated+%28M2%29+Macrophage+Phenotype+Is+Inducible+by+Endothelin-1+in+Cultured+Human+Macrophages&rft.jtitle=PloS+one&rft.au=Stefano+Soldano&rft.au=Carmen+Pizzorni&rft.au=Sabrina+Paolino&rft.au=Amelia+Chiara+Trombetta&rft.date=2016-11-15&rft.pub=Public+Library+of+Science+%28PLoS%29&rft.eissn=1932-6203&rft.volume=11&rft.issue=11&rft.spage=e0166433&rft_id=info:doi/10.1371%2Fjournal.pone.0166433&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_94b267c2ed2a4cfdb604c063e389d3bc
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon